UGC Approved Journal no 63975(19)
New UGC Peer-Reviewed Rules

ISSN: 2349-5162 | ESTD Year : 2014
Volume 13 | Issue 9 | September 2026

JETIREXPLORE- Search Thousands of research papers



WhatsApp Contact
Click Here

Published in:

Volume 13 Issue 9
September-2026
eISSN: 2349-5162

UGC and ISSN approved 7.95 impact factor UGC Approved Journal no 63975

7.95 impact factor calculated by Google scholar

Unique Identifier

Published Paper ID:
JETIR2609095


Registration ID:
585496

Page Number

a750-a770

Share This Article


Jetir RMS

Title

Method Development and Validation for Estimation of Ziprasidone in marketed formulation by using RP-HPLC

Abstract

Proposed method was found to be linear in the range of 5-25 μg/ml Ziprasidone with the correlation coefficient near to one respectively. The validation and the reliability of proposed method were assessed by recovery study. The recovery of added standards (80%, 100% 120%) was ranging from 99.62 to 99.784%, for Ziprasidone. Liquid chromatographic system from waters comprising of manual injector, Waters 515 binary pump for constant flow and constant pressure delivery and U.V. detector connected to data ace software controlling the instrumentation as well as processing methanol: Acetonitrile in the ratio of 50:50 v/v at a flow rate of 1.0 ml min-1. A thermo C-18 column (4.6 x 250mm, 5μ particle size) was used as the stationary phase, 250.0 nm was selected as the detection wavelength for UV-vis. detector. The proposed methods were found to be linear in the range of 5-25 μg/ml with correlation coefficient close to one. Precision was determined by repeatability, Intermediate precision and reproducibility of the drugs. The robustness of developed method was checked by changing in the deliberate variation in solvent. The result obtained shows the developed methods to be Cost effective, Rapid (Short retention time), Simple, Accurate (the value of SD and %RSD less than 2), Precise and can be successfully employed in the routine analysis of these drugs in bulk drug as well as in tablet dosage form.

Key Words

Ziprasidone, Method development, Validation, HPLC, Dosage form.

Cite This Article

"Method Development and Validation for Estimation of Ziprasidone in marketed formulation by using RP-HPLC", International Journal of Emerging Technologies and Innovative Research (www.jetir.org), ISSN:2349-5162, Vol.13, Issue 9, page no.a750-a770, September-2026, Available :http://www.jetir.org/papers/JETIR2609095.pdf

ISSN


2349-5162 | Impact Factor 7.95 Calculate by Google Scholar

An International Scholarly Open Access Journal, Peer-Reviewed, Refereed Journal Impact Factor 7.95 Calculate by Google Scholar and Semantic Scholar | AI-Powered Research Tool, Multidisciplinary, Monthly, Multilanguage Journal Indexing in All Major Database & Metadata, Citation Generator

Cite This Article

"Method Development and Validation for Estimation of Ziprasidone in marketed formulation by using RP-HPLC", International Journal of Emerging Technologies and Innovative Research (www.jetir.org | UGC and issn Approved), ISSN:2349-5162, Vol.13, Issue 9, page no. ppa750-a770, September-2026, Available at : http://www.jetir.org/papers/JETIR2609095.pdf

Publication Details

Published Paper ID: JETIR2609095
Registration ID: 585496
Published In: Volume 13 | Issue 9 | Year September-2026
DOI (Digital Object Identifier):
Page No: a750-a770
Country: -, -, India .
Area: Pharmacy
ISSN Number: 2349-5162
Publisher: IJ Publication


Preview This Article


Downlaod

Click here for Article Preview

Download PDF

Downloads

0008

Print This Page

Current Call For Paper

Jetir RMS